Southwestern internal medicine conference

Norman M Kaplan, Biff F Palmer, Factor V. Leiden, Ray Lee

Research output: Contribution to journalArticle

Abstract

Factor V Leiden is the most prevalent genetic thrombophilia in people of European descent. Since its discovery, much clinical information has been gathered regarding the distribution and prevalence of the genetic mutation, the mechanism of thrombophilia, and its association with clinical thromboembolic events. Although its association with venous thromboembolism is clear, the role of Factor V Leiden in other disease states is not clear. A review of the literature regarding the mechanism of hypercoagulability, genetic versus functional diagnostic tests, screening issues, relationship to arterial thromboses, pregnancy and pregnancy complications, and treatment are discussed.

Original languageEnglish (US)
Pages (from-to)88-102
Number of pages15
JournalAmerican Journal of the Medical Sciences
Volume322
Issue number2
StatePublished - 2001

Fingerprint

Thrombophilia
Internal Medicine
Pregnancy Complications
Venous Thromboembolism
Routine Diagnostic Tests
Thrombosis
Pregnancy
Mutation
factor V Leiden

Keywords

  • Factor V Leiden
  • Risk factor
  • Thromboembolism
  • Thrombophilia
  • Venous thrombosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Southwestern internal medicine conference. / Kaplan, Norman M; Palmer, Biff F; Leiden, Factor V.; Lee, Ray.

In: American Journal of the Medical Sciences, Vol. 322, No. 2, 2001, p. 88-102.

Research output: Contribution to journalArticle

Kaplan, Norman M ; Palmer, Biff F ; Leiden, Factor V. ; Lee, Ray. / Southwestern internal medicine conference. In: American Journal of the Medical Sciences. 2001 ; Vol. 322, No. 2. pp. 88-102.
@article{6b672271992a447b889a3146d7ef1435,
title = "Southwestern internal medicine conference",
abstract = "Factor V Leiden is the most prevalent genetic thrombophilia in people of European descent. Since its discovery, much clinical information has been gathered regarding the distribution and prevalence of the genetic mutation, the mechanism of thrombophilia, and its association with clinical thromboembolic events. Although its association with venous thromboembolism is clear, the role of Factor V Leiden in other disease states is not clear. A review of the literature regarding the mechanism of hypercoagulability, genetic versus functional diagnostic tests, screening issues, relationship to arterial thromboses, pregnancy and pregnancy complications, and treatment are discussed.",
keywords = "Factor V Leiden, Risk factor, Thromboembolism, Thrombophilia, Venous thrombosis",
author = "Kaplan, {Norman M} and Palmer, {Biff F} and Leiden, {Factor V.} and Ray Lee",
year = "2001",
language = "English (US)",
volume = "322",
pages = "88--102",
journal = "The American journal of the medical sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Southwestern internal medicine conference

AU - Kaplan, Norman M

AU - Palmer, Biff F

AU - Leiden, Factor V.

AU - Lee, Ray

PY - 2001

Y1 - 2001

N2 - Factor V Leiden is the most prevalent genetic thrombophilia in people of European descent. Since its discovery, much clinical information has been gathered regarding the distribution and prevalence of the genetic mutation, the mechanism of thrombophilia, and its association with clinical thromboembolic events. Although its association with venous thromboembolism is clear, the role of Factor V Leiden in other disease states is not clear. A review of the literature regarding the mechanism of hypercoagulability, genetic versus functional diagnostic tests, screening issues, relationship to arterial thromboses, pregnancy and pregnancy complications, and treatment are discussed.

AB - Factor V Leiden is the most prevalent genetic thrombophilia in people of European descent. Since its discovery, much clinical information has been gathered regarding the distribution and prevalence of the genetic mutation, the mechanism of thrombophilia, and its association with clinical thromboembolic events. Although its association with venous thromboembolism is clear, the role of Factor V Leiden in other disease states is not clear. A review of the literature regarding the mechanism of hypercoagulability, genetic versus functional diagnostic tests, screening issues, relationship to arterial thromboses, pregnancy and pregnancy complications, and treatment are discussed.

KW - Factor V Leiden

KW - Risk factor

KW - Thromboembolism

KW - Thrombophilia

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0034886679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034886679&partnerID=8YFLogxK

M3 - Article

VL - 322

SP - 88

EP - 102

JO - The American journal of the medical sciences

JF - The American journal of the medical sciences

SN - 0002-9629

IS - 2

ER -